Isolation and profiling of plasma microRNAs: Biomarkers for asthma and allergic rhinitis

Ronaldo P. Panganiban, Kristin A. Lambert, Man Hsun Hsu, Zoe Laryea, Faoud Ishmael

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronic inflammatory diseases can be particularly challenging to diagnose and characterize, as inflammatory changes in tissue may not be present in blood. There is a crucial need to develop non-invasive biomarkers that would be useful in diagnosing disease and selecting medical therapies. For example, there are no blood tests to diagnose asthma, a common inflammatory lung disease. MicroRNA (miRNA) expression profiling in blood is emerging as a potentially sensitive and useful biomarker of many diseases. In particular, we have characterized a cost-effective PCR-based array technology to measure and profile circulating miRNAs in the plasma of patients with allergic rhinitis and asthma. Here, we describe the methods to isolate, quantify, and analyze miRNAs in the plasma of human subjects as well as ways to determine their diagnostic utility.

Original languageEnglish (US)
Pages (from-to)48-54
Number of pages7
JournalMethods
Volume152
DOIs
StatePublished - Jan 1 2019

Fingerprint

Biomarkers
MicroRNAs
Blood
Asthma
Plasmas
Pulmonary diseases
Hematologic Tests
Lung Diseases
Chronic Disease
Tissue
Technology
Costs and Cost Analysis
Polymerase Chain Reaction
Allergic Rhinitis
Costs
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Panganiban, Ronaldo P. ; Lambert, Kristin A. ; Hsu, Man Hsun ; Laryea, Zoe ; Ishmael, Faoud. / Isolation and profiling of plasma microRNAs : Biomarkers for asthma and allergic rhinitis. In: Methods. 2019 ; Vol. 152. pp. 48-54.
@article{b30420fbec6741f4833ea0f58b7647e8,
title = "Isolation and profiling of plasma microRNAs: Biomarkers for asthma and allergic rhinitis",
abstract = "Chronic inflammatory diseases can be particularly challenging to diagnose and characterize, as inflammatory changes in tissue may not be present in blood. There is a crucial need to develop non-invasive biomarkers that would be useful in diagnosing disease and selecting medical therapies. For example, there are no blood tests to diagnose asthma, a common inflammatory lung disease. MicroRNA (miRNA) expression profiling in blood is emerging as a potentially sensitive and useful biomarker of many diseases. In particular, we have characterized a cost-effective PCR-based array technology to measure and profile circulating miRNAs in the plasma of patients with allergic rhinitis and asthma. Here, we describe the methods to isolate, quantify, and analyze miRNAs in the plasma of human subjects as well as ways to determine their diagnostic utility.",
author = "Panganiban, {Ronaldo P.} and Lambert, {Kristin A.} and Hsu, {Man Hsun} and Zoe Laryea and Faoud Ishmael",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ymeth.2018.06.007",
language = "English (US)",
volume = "152",
pages = "48--54",
journal = "Methods",
issn = "1046-2023",
publisher = "Academic Press Inc.",

}

Isolation and profiling of plasma microRNAs : Biomarkers for asthma and allergic rhinitis. / Panganiban, Ronaldo P.; Lambert, Kristin A.; Hsu, Man Hsun; Laryea, Zoe; Ishmael, Faoud.

In: Methods, Vol. 152, 01.01.2019, p. 48-54.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Isolation and profiling of plasma microRNAs

T2 - Biomarkers for asthma and allergic rhinitis

AU - Panganiban, Ronaldo P.

AU - Lambert, Kristin A.

AU - Hsu, Man Hsun

AU - Laryea, Zoe

AU - Ishmael, Faoud

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic inflammatory diseases can be particularly challenging to diagnose and characterize, as inflammatory changes in tissue may not be present in blood. There is a crucial need to develop non-invasive biomarkers that would be useful in diagnosing disease and selecting medical therapies. For example, there are no blood tests to diagnose asthma, a common inflammatory lung disease. MicroRNA (miRNA) expression profiling in blood is emerging as a potentially sensitive and useful biomarker of many diseases. In particular, we have characterized a cost-effective PCR-based array technology to measure and profile circulating miRNAs in the plasma of patients with allergic rhinitis and asthma. Here, we describe the methods to isolate, quantify, and analyze miRNAs in the plasma of human subjects as well as ways to determine their diagnostic utility.

AB - Chronic inflammatory diseases can be particularly challenging to diagnose and characterize, as inflammatory changes in tissue may not be present in blood. There is a crucial need to develop non-invasive biomarkers that would be useful in diagnosing disease and selecting medical therapies. For example, there are no blood tests to diagnose asthma, a common inflammatory lung disease. MicroRNA (miRNA) expression profiling in blood is emerging as a potentially sensitive and useful biomarker of many diseases. In particular, we have characterized a cost-effective PCR-based array technology to measure and profile circulating miRNAs in the plasma of patients with allergic rhinitis and asthma. Here, we describe the methods to isolate, quantify, and analyze miRNAs in the plasma of human subjects as well as ways to determine their diagnostic utility.

UR - http://www.scopus.com/inward/record.url?scp=85049758168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049758168&partnerID=8YFLogxK

U2 - 10.1016/j.ymeth.2018.06.007

DO - 10.1016/j.ymeth.2018.06.007

M3 - Article

C2 - 29906503

AN - SCOPUS:85049758168

VL - 152

SP - 48

EP - 54

JO - Methods

JF - Methods

SN - 1046-2023

ER -